Kaiser Foundation Health Plan Southern California |
Keytruda (pembrolizumab) |
Drugs for Cancer : Drugs for Cancer |
- Short Bowel Syndrome:
Age Requirement: >= 1
Duration: 12 Month(s)
Specialist Required: Yes
Documented Diagnosis: Yes
Medical Test Required: No
Specialist Type(s): Gastroenterologist
Reauthorization Required: Yes
Duration of Reauthorization: >= 12 month(s)
- Quantity Limit: 1 tablet per day)
|